AGMB-129

· Agomab Spain S.L.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AGMB-129, covering 2024-05-16 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants [Phase 1]